Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

December 19, 2007 | Customer News

Tecan pumps chosen for accuracy, speed and robustness


Scintomics GmbH in Germany has chosen Tecan’s Cavro® syringe pumps as components for its automated synthesizing modules, which produce radiolabeled chemical compounds for targeted molecular imaging in cancer patients. Hans-Jürgen Wester, Professor for Radiopharmaceutical Chemistry at the Technical University of Munich, and co-founder of Scintomics, explained: “We develop and produce fully automated radiopharmaceutical synthesizers, which are essentially very small chemical plants to prepare radioactive tracers for clinical applications. These chemical compounds need to be synthesized very quickly due to the short half-life of the isotopes used.”

“We chose Tecan’s syringe pumps as components for our systems because of their accuracy, the speed they take to transfer liquids, and because Tecan products are well known for their robustness, which is exactly what we need in high quality products for medicinal applications. Another advantage is their high resolution; the next generation of Scintomics’ chemical synthesizers will involve the use of microfluidics and, because very small volumes and flow rates are used in our applications, Tecan’s pumps will be a major advantage for us.”

About Tecan

Tecan (www.tecan.com) is a leading global supplier of solutions for the biopharma, forensic and diagnostic industries. The company is a leader in the development, production and distribution of advanced automation and detection solutions for the world’s leading life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of large-scale automated laboratory storage and logistics systems. Founded in Switzerland in 1980, the company has over 1100 employees, owns production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2006, Tecan achieved sales of CHF 405.9 million (USD 324.7 million; EUR 258.6 million). Shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).

For further information please contact:

Tecan Group Ltd.
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12